About the Event

When Avior Bio’s founder, President, and CEO, Niraj Vasisht, PhD saw his uncle suffering from pruritis brought on by liver disease, he knew he had to do something. There are no effective treatments for the persistent and intractable itching that approximately 20 million Americans suffer from.

Often described as like having bugs crawling under your skin 24 hours a day, pruritus is a debilitating condition that causes worsening quality-of-life, sleep disturbance, depression, severe excoriation, bleeding, and increased mortality risks. Avior is well on its way to developing the first and only once-daily oral transmucosal film treatment for pruritis.

Join our webinar to hear from Mr. Vasisht, and how Avior is ready to enter Phase 2 Clinical Trials for its treatment for pruritis, a $1.3 billion market opportunity with a clear unmet need.

Date & Time

January 6 at 3:00 PM ET
Webinar: Details provided upon RSVP approval

Once you click the RSVP button above, you will be redirected to a Zoom webinar registration page.


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.